New app aims to ease daily struggles for kidney dialysis patients
NCT ID NCT07211100
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a mobile app designed for people on hemodialysis. The app helps with medication, diet, fluid limits, and symptom tracking. 72 adults will be split into two groups: one uses the app, the other gets standard care. Researchers will check if the app improves treatment adherence and reduces symptoms like fatigue and itching over two months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mobile health application
What this could lead to
If it works, this app could help hemodialysis patients better manage their diet, fluids, and symptoms, improving daily life and treatment adherence.
What could go wrong
This is a small, early-stage study with only 72 people over 2 months. The app may not show clear benefits, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE REQUIRING HAEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gumushane State Hospital
Gümüşhane, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••